ZUCCS’16 | A Global Invitation to Advance Colorectal Cancer Care

ZUCCS’16 | A Global Invitation to Advance Colorectal Cancer Care

Globally, colorectal cancer is the third most commonly diagnosed malignancy and the second leading cause of cancer-related death, placing a substantial burden on public health worldwide. Owing to its large population base, China accounts for 28.76% of global colorectal cancer incidence and 30.60% of related deaths, making it a major driving force in advancing colorectal cancer prevention and treatment worldwide. In recent years, breakthroughs in innovative drug development, novel surgical techniques, and robotic-assisted surgery in China have significantly advanced the global standard of colorectal cancer care.
4th Clinical Research Conference on Urologic Oncology | Breaking Through the Post-PD-1 Era: Professor Xieqiao Yan Interprets the Latest Advances in Kidney Cancer Research from ASCO GU 2026

4th Clinical Research Conference on Urologic Oncology | Breaking Through the Post-PD-1 Era: Professor Xieqiao Yan Interprets the Latest Advances in Kidney Cancer Research from ASCO GU 2026

At the 2026 American Society of Clinical Oncology Genitourinary Cancers Symposium (ASCO GU), Professor Xieqiao Yan from Peking University Cancer Hospital delivered a comprehensive presentation on the latest advances in kidney cancer therapy. His report focused on emerging clinical evidence surrounding the HIF-2α inhibitor belzutifan, particularly its evolving role in advanced clear cell renal cell carcinoma (ccRCC) after PD-1–based therapy, as well as in the postoperative adjuvant setting. The findings offer important new insights for clinical decision-making in the post-PD-1 era.
2nd Peking University Urology Academic Forum | Professor Jianye Wang: Current Priorities, Clinical Challenges, and Future Directions in Urinary Continence and Pelvic Floor Disorders

2nd Peking University Urology Academic Forum | Professor Jianye Wang: Current Priorities, Clinical Challenges, and Future Directions in Urinary Continence and Pelvic Floor Disorders

Urinary continence and pelvic floor disorders represent an important subspecialty within urology. Conditions such as post-prostatectomy urinary incontinence and overactive bladder (OAB), which are particularly common in elderly populations, can severely compromise patients’ quality of life.
2nd Peking University Urology Academic Forum | Professor Xuesong Li: Innovation and Leadership in Integrated Management of Benign and Malignant Upper Urinary Tract Diseases

2nd Peking University Urology Academic Forum | Professor Xuesong Li: Innovation and Leadership in Integrated Management of Benign and Malignant Upper Urinary Tract Diseases

The 2nd Peking University Urology Academic Forum focused on the integrated and collaborative management of benign and malignant diseases of the upper urinary tract. As conference chair, Professor Xuesong Li from the Department of Urology at Peking University First Hospital shared his team’s long-standing experience and insights into the field’s major clinical challenges, key innovations, and future directions.
2nd Peking University Urology Academic Forum | Professor Chaohui Gu: Umbilical Artery Ligament Suspension—A New Breakthrough for Immediate Urinary Continence After Radical Prostatectomy

2nd Peking University Urology Academic Forum | Professor Chaohui Gu: Umbilical Artery Ligament Suspension—A New Breakthrough for Immediate Urinary Continence After Radical Prostatectomy

At the 2nd Peking University Urology Academic Forum and the 80th Anniversary Celebration of the Department of Urology at Peking University First Hospital, Oncology Frontier – UroStream  interviewed Professor Chaohui Gu from the Department of Urology, The First Affiliated Hospital of Zhengzhou University.
AOT 2026 | Professor Xiaojun Huang Leads In-Depth Discussions on Three Major Controversies in Hematopoietic Stem Cell Transplantation

AOT 2026 | Professor Xiaojun Huang Leads In-Depth Discussions on Three Major Controversies in Hematopoietic Stem Cell Transplantation

Academic progress begins with debate and matures through consensus. As a cornerstone therapy for hematologic diseases, hematopoietic stem cell transplantation (HSCT) continues to face numerous unresolved controversies and clinical dilemmas. Centered on the theme “The Art of Transplantation,” the 2026 Beijing International Hematopoietic Stem Cell Transplantation Conference (AOT 2026) brought together leading experts from around the world to discuss technological innovation and future directions in transplantation medicine.